栝楼桂枝颗粒对脑缺血再灌注损伤大鼠的血脑屏障通透性及神经保护作用

被引:15
作者
张玉琴 [1 ]
李煌 [2 ]
许文 [2 ]
徐伟 [2 ]
黄枚 [2 ]
褚克丹 [2 ]
陈立典 [3 ]
机构
[1] 福建中医药大学中西医结合研究院
[2] 福建中医药大学药学院
[3] 福建中医药大学康复医学院
关键词
栝楼桂枝颗粒; 血脑屏障; 脑缺血再灌注损伤; HPLC-MS/MS; 神经保护;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
目的:探讨栝楼桂枝颗粒(GLGZG)对脑缺血再灌注损伤大鼠的血脑屏障(BBB)通透性的影响及神经保护作用。方法:文章采用大脑中动脉栓线阻断法制备局灶性脑缺再灌注损伤模型(MCAO),缺血2h后进行再灌注。采用HPLC-MS/MS定性分析正常大鼠及MCAO模型大鼠血浆、脑组织及脑脊液中GLGZG的成分。同时观察MCAO模型大鼠的神经功能缺损、BBB通透性变化、脑梗死体积测定和病理组织学变化。结果:经HPLC-MS/MS定性分析得出,GLGZG中的成分瓜氨酸、芍药内酯苷、芍药苷、芹糖甘草苷、甘草苷可以通过BBB进入脑组织中,而在模型组中,成分异甘草素以及甘草酸亦可在脑组织或脑脊液中检测到。同时GLGZG能降低MCAO模型大鼠的神经功能缺损、减少伊文思蓝(EB)的渗透量、缩小脑梗死体积、减轻脑缺血再灌注的病理组织损伤。结论:GLGZG中的成分瓜氨酸、芍药内酯苷、芍药苷、芹糖甘草苷、甘草苷、芹糖异甘草苷、异甘草苷、甘草素、异甘草素以及甘草酸可以透过BBB进入脑组织中,对脑缺血再灌注损伤的大鼠起到神经保护作用,为今后进一步研究及临床用药提供实验依据。
引用
收藏
页码:1410 / 1417
页数:8
相关论文
共 24 条
[11]  
Neuroprotective effects of Gualou Guizhi decoction in vivo and in vitro[J] . Yuqin Zhang,Huang Li,Mei Huang,Kedan Chu,Wei Xu,Shengnan Zhang,Jinhua Que,Lidian Chen.Journal of Ethnopharmacology . 2014
[12]   Effect of Gua Lou Gui Zhi decoction on focal cerebral ischemia-reperfusion injury through regulating the expression of excitatory amino acids and their receptors [J].
Chen, Xianwen ;
Li, Huang ;
Huang, Mingqing ;
Huang, Mei ;
Xu, Wei ;
Chu, Kedan ;
Chen, Lidian ;
Zhang, Yuqin .
MOLECULAR MEDICINE REPORTS, 2014, 10 (01) :248-254
[13]   Gua Lou Gui Zhi decoction exerts neuroprotective effects on post-stroke spasticity via the modulation of glutamate levels and AMPA receptor expression [J].
Huang, Jia ;
Tao, Jing ;
Xue, Xiehua ;
Yang, Shanli ;
Han, Ping ;
Lin, Zhicheng ;
Xu, Wei ;
Lin, Jiumao ;
Peng, Jun ;
Chen, Lidian .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 31 (04) :841-848
[14]   Gua Lou Gui Zhi decoction suppresses LPS-induced activation of the TLR4/NF-κB pathway in BV-2 murine microglial cells [J].
Hu, Haixia ;
Li, Zuanfang ;
Zhu, Xiaoqin ;
Lin, Ruhui ;
Lin, Jiumao ;
Peng, Jun ;
Tao, Jing ;
Chen, Lidian .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 31 (06) :1327-1332
[15]   GuaLou GuiZhi decoction inhibits LPS-induced microglial cell motility through the MAPK signaling pathway [J].
Hu, Haixia ;
Li, Zuanfang ;
Zhu, Xiaoqin ;
Lin, Ruhui ;
Peng, Jun ;
Tao, Jing ;
Chen, Lidian .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 (06) :1281-1286
[16]  
Cerebralcare Granule? attenuates blood–brain barrier disruption after middle cerebral artery occlusion in rats[J] . Ping Huang,Chang-Man Zhou,Qin-Hu,Yu-Ying Liu,Bai-He Hu,Xin Chang,Xin-Rong Zhao,Xiang-Shun Xu,Quan Li,Xiao-Hong Wei,Xiao-Wei Mao,Chuan-She Wang,Jing-Yu Fan,Jing-Yan Han.Experimental Neurology . 2012 (2)
[17]   Blood-brain barrier tight junction permeability and ischemic stroke [J].
Sandoval, Karin E. ;
Witt, Ken A. .
NEUROBIOLOGY OF DISEASE, 2008, 32 (02) :200-219
[18]  
The blood–brain barrier is continuously open for several weeks following transient focal cerebral ischemia[J] . D. Strbian,A. Durukan,M. Pitkonen,I. Marinkovic,E. Tatlisumak,E. Pedrono,U. Abo-Ramadan,T. Tatlisumak.Neuroscience . 2008 (1)
[19]   Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats [J].
Zhan, C ;
Yang, J .
PHARMACOLOGICAL RESEARCH, 2006, 53 (03) :303-309
[20]  
?dème cérébral par lésion de la barrière hématoencéphalique : mécanismes et diagnostic[J] . J.F Payen,B Fauvage,D Falcon,P Lavagne.Annales francaises d’anesthesie et de reanimation . 2003 (3)